Optina Diagnostics Inc. Asset Profile

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

Year established

2011

Location

Montreal QC Canada

Primary Industry

Medical Devices & Equipment

About

Based in Quebec, Canada, and founded in 2011, Optina Diagnostics Inc. operates as a developer of a retinal imaging and diagnotic tool used for the early detection of Alzheimer's disease. In January 2022, Optina Diagnostics Inc. raised USD 2.1 million in venture funding led by the Alzheimer's Drug Discovery Foundation. As of 2024, the company is led by its CEO and president, David Lapointe. The company’s primary product, Optina-4C™, utilizes optical techniques originally developed for astronomical studies to examine the inner lining of the eye. This approach enables the detection of amyloid pathology, an indicator of Alzheimer’s disease, at its earliest stages. Optina's technology provides benefits for patients, physicians, and eye specialists. Patients gain information about their brain health, which can inform treatment decisions and potentially delay or reverse symptoms. Physicians are equipped with tools to support their patients, while eye specialists can expand their services to include brain health assessments.

Current Investors

Desjardins Capital, Pallasite Ventures, Advisors.fund

Request a demo to show more

Primary Industry

Medical Devices & Equipment

Sub Industries

Optometrists & Opticians Products and Services, Diagnostic Equipment

Website

www.optinadx.com/

Company Stage

Series A

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.